We are live on ! Find out more
TVRD

Tvardi Therapeutics
TVRD

101 hedge funds and large institutions have $129M invested in Tvardi Therapeutics in 2016 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 31 increasing their positions, 23 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

205% more call options, than puts

Call options by funds: $1.78M | Put options by funds: $583K

167% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 12

35% more capital invested

Capital invested by funds: $95.5M → $129M (+$33.4M)

35% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 23

25% more funds holding

Funds holding: 81 → 101 (+20)

1.41% more ownership

Funds ownership: 0% → 1.41% (+1.4%)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
101
Holders Change
+20
Holders Change %
+24.69%
% of All Funds
2.52%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
32
Increased
31
Reduced
23
Closed
12
Calls
$1.78M
Puts
$583K
Net Calls
+$1.19M
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DGI
Disciplined Growth Investors
Minnesota
+$7.92M
2
EAM
EverPoint Asset Management
Connecticut
+$2.67M
3
NC
Nexthera Capital
New York
+$2.23M
4
EI
EAM Investors
California
+$2.14M
5
BIT
BlackRock Institutional Trust
California
+$1.81M

Top Sellers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
-$2.33M
2
Renaissance Technologies
Renaissance Technologies
New York
-$2.07M
3
OM
Opaleye Management
Massachusetts
-$1.78M
4
Allianz Asset Management
Allianz Asset Management
Germany
-$1.05M
5
Morgan Stanley
Morgan Stanley
New York
-$897K
Name Holding Trade Value Shares
Change 		Change in
Stake
Simplex Trading
76
Simplex Trading
Illinois
$28K +$27K +84 New
GWM
77
Geneos Wealth Management
Colorado
$24K +$14.1K +44 +142%
AG
78
Advisor Group
Arizona
$24K +$22.5K +70 +7,000%
MFS
79
MSI Financial Services
Massachusetts
$19K -$8.66K -27 -33%
CSS
80
Cubist Systematic Strategies
Connecticut
$19K +$15.1K +47 +588%
Royal Bank of Canada
81
Royal Bank of Canada
Ontario, Canada
$18K +$8.66K +27 +100%
TRCT
82
Tower Research Capital (TRC)
New York
$16K -$35.6K -111 -70%
WA
83
WFG Advisors
Texas
$16K +$15.7K +49 New
SEI Investments
84
SEI Investments
Pennsylvania
$15K – – –
MAM
85
Meeder Asset Management
Ohio
$15K +$15.1K +47 New
PFGIA
86
Patriot Financial Group Insurance Agency
Massachusetts
$14K +$10.6K +33 New
AA
87
AlphaMark Advisors
Kentucky
$13K – – –
GEA
88
Glen Eagle Advisors
New Jersey
$10.7K +$10.3K +32 New
SIM
89
Sonora Investment Management
Arizona
$7.43K – – –
IA
90
IFP Advisors
Florida
$7K +$7.06K +22 New
Citigroup
91
Citigroup
New York
$5K – – –
HCM
92
Horrell Capital Management
Arkansas
$5K – – –
LTFS
93
Ladenburg Thalmann Financial Services
Florida
$4K +$1.28K +4 +50%
NIT
94
NumerixS Investment Technologies
British Columbia, Canada
$4K +$3.53K +11 New
MWM
95
MinichMacGregor Wealth Management
New York
$4K +$4.49K +14 New
AWM
96
Avior Wealth Management
Nebraska
$3K +$2.57K +8 New
PNC Financial Services Group
97
PNC Financial Services Group
Pennsylvania
$2K +$2.25K +7 New
BNP Paribas Financial Markets
98
BNP Paribas Financial Markets
France
$1.48K -$11.2K -35 -90%
MTIP
99
Magee Thomson Investment Partners
California
$1K -$321 -1 -25%
KF
100
Krilogy Financial
Missouri
$1K +$963 +3 New
1 2 3
4
5

TVRD Hedge Fund Activity: Q4 2016 in Review

101 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Tvardi Therapeutics (TVRD) for Q4 2016, worth a combined $129M — up 35% from $95.5M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new TVRD positions and 12 closed out — a net gain of 20 holders — while 31 added to existing stakes and 23 trimmed.

The largest buyer was Disciplined Growth Investors, opening a new position worth an estimated $7.92M. The largest seller was BlackRock Fund Advisors, cutting an estimated $2.33M.

  • 101 institutional investors held Tvardi Therapeutics (TVRD) as of Q4 2016, up from 81 in Q3 2016.
  • Funds reported $129M of Tvardi Therapeutics stock for Q4 2016, up 35% quarter-over-quarter.
  • 32 funds opened new Tvardi Therapeutics positions in Q4 2016 and 12 closed out, a net change of +20 holders.
  • The largest Tvardi Therapeutics buyer in Q4 2016 was Disciplined Growth Investors, an estimated $7.92M added.
  • The largest Tvardi Therapeutics seller in Q4 2016 was BlackRock Fund Advisors, an estimated $2.33M sold.

Based on aggregated 13F filings for Q4 2016.